Treatment of Complicated Staphylococcus aureus Bacteremia

JAMA Author Interviews: Covering research in medicine, science, & clinical practice. For physicians, researchers, & clinicians. by American Medical Association

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke Unive...View more